Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicure (MCUJF) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to -$922597.8.

  • Medicure's Income towards Parent Company fell 28508.36% to -$922597.8 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 73400.28%. This contributed to the annual value of $377252.5 for FY2024, which is 4110.17% down from last year.
  • As of Q3 2025, Medicure's Income towards Parent Company stood at -$922597.8, which was down 28508.36% from -$483547.4 recorded in Q2 2025.
  • Medicure's Income towards Parent Company's 5-year high stood at $4.0 million during Q4 2022, with a 5-year trough of -$1.5 million in Q4 2021.
  • Moreover, its 5-year median value for Income towards Parent Company was $286614.2 (2023), whereas its average is $285274.6.
  • As far as peak fluctuations go, Medicure's Income towards Parent Company surged by 328403.8% in 2021, and later plummeted by 123796.48% in 2025.
  • Quarter analysis of 5 years shows Medicure's Income towards Parent Company stood at -$1.5 million in 2021, then soared by 370.66% to $4.0 million in 2022, then tumbled by 95.45% to $180695.7 in 2023, then soared by 119.08% to $395864.6 in 2024, then plummeted by 333.06% to -$922597.8 in 2025.
  • Its Income towards Parent Company was -$922597.8 in Q3 2025, compared to -$483547.4 in Q2 2025 and -$430694.4 in Q1 2025.